Stock TVTX TRAVERE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Travere Therapeutics, Inc.

Equities

TVTX

US89422G1076

Real-time Estimate Cboe BZX
Other stock markets
 10:10:08 2024-05-14 am EDT 		5-day change 1st Jan Change
6.565 USD +3.55% Intraday chart for Travere Therapeutics, Inc. -2.67% -26.92%
May. 07 Canaccord Genuity Adjusts Price Target on Travere Therapeutics to $18 From $15, Maintains Buy Rating MT
May. 06 Travere Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. TVTX Stock
  4. News Travere Therapeutics, Inc.
  5. Official Publications
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW